These findings collectively suggest that DCM patients harboring pathogenic variants in high-risk genes (such as LMNA, EMD, TMEM43, DSP, RBM20, and PLN, and truncating variants of FLNC) should be identified as having a predisposition to SCD [66]. This evidence concerns the gene RBM20 and familial dilated cardiomyopathy.